Panion & Bf Biotech Inc. Stock Price

TWSE:1760 Community·NT$4.6b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Author Program NEW Create Narrative

1760 Share Price Performance

NT$54.10

-16.70 (-23.59%)

NT$54.10

-16.70 (-23.59%)

NT$54.10

Sun, 13 Sep 26

Share Pricen/a

1760 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

No trending discussion available.

Snowflake Analysis

Flawless balance sheet with solid track record.

1 Risk

2 Rewards

View Full Analysis

Panion & Bf Biotech Inc. Key Details

Last Reported Earnings

Jun 30, 2026

Next Reporting Earnings

n/a

: 2.51
: 52.85%
: 10.19%
: 31.7%

View Full Analysis

About 1760

Founded: 1976
Employees: n/a
CEO: Tsung-Ming Chiang
WebsiteView website: www.pbf.com.tw

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei, Taiwan.